Scrip Asks…What Does 2021 Hold For Biopharma? Part 5: Business Environment And Strategy
Bullish Sector Outlook As Technological Progress Drives Growth
A strong year is predicted for biopharma business with investment and deal making set to continue apace. Executives across industry share their forecasts for the year ahead.
